CSPC Pharmaceutical Group Limited

BMV:1093 N Stock Report

Market Cap: Mex$151.7b

CSPC Pharmaceutical Group Future Growth

Future criteria checks 0/6

CSPC Pharmaceutical Group is forecast to grow earnings and revenue by 1.4% and 3.7% per annum respectively. EPS is expected to grow by 1.5% per annum. Return on equity is forecast to be 13.6% in 3 years.

Key information

1.4%

Earnings growth rate

1.5%

EPS growth rate

Pharmaceuticals earnings growth19.4%
Revenue growth rate3.7%
Future return on equity13.6%
Analyst coverage

Good

Last updated29 Jan 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BMV:1093 N - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202631,6954,6506,184N/A3
12/31/202538,2787,2566,277N/A24
12/31/202435,1986,7386,097N/A27
12/31/202332,0366,1625,281N/A25
9/30/202331,3066,118N/AN/AN/A
6/30/202331,4076,0921,9854,690N/A
3/31/202331,1166,116N/AN/AN/A
12/31/202230,9376,0914,9227,627N/A
9/30/202230,7215,738N/AN/AN/A
6/30/202229,6555,5094,0986,151N/A
3/31/202229,0075,538N/AN/AN/A
12/31/202127,8675,6052,8874,637N/A
9/30/202126,3695,977N/AN/AN/A
6/30/202126,1755,9085,8657,053N/A
3/31/202125,5515,472N/AN/AN/A
12/31/202024,9425,1605,3626,740N/A
9/30/202024,5584,421N/AN/AN/A
6/30/202023,5154,1503,1294,614N/A
3/31/202022,7353,922N/AN/AN/A
12/31/201922,1033,7141,8353,784N/A
9/30/201921,3353,625N/AN/AN/A
6/30/201920,1353,4541,3703,743N/A
3/31/201918,8353,294N/AN/AN/A
12/31/201817,7173,0811,9223,795N/A
9/30/201816,8772,905N/AN/AN/A
6/30/201815,7292,7341,8273,352N/A
3/31/201813,9592,443N/AN/AN/A
12/31/201712,8772,3071,7292,738N/A
9/30/201712,2032,195N/AN/AN/A
6/30/201711,6592,068N/A2,811N/A
3/31/201711,3831,979N/AN/AN/A
12/31/201611,0751,881N/A2,611N/A
9/30/201610,4391,711N/AN/AN/A
6/30/201610,1181,607N/A2,147N/A
3/31/20169,6561,473N/AN/AN/A
12/31/20159,5451,395N/A1,884N/A
9/30/20159,2841,305N/AN/AN/A
6/30/20159,0721,192N/A1,192N/A
3/31/20158,9191,126N/AN/AN/A
12/31/20148,7621,015N/A1,445N/A
9/30/20148,423896N/AN/AN/A
6/30/20148,197849N/A1,059N/A
3/31/20148,001814N/AN/AN/A
12/31/20137,768760N/A636N/A
9/30/20137,3451,967N/AN/AN/A
6/30/20136,1561,927N/A550N/A
3/31/20134,8181,806N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1093 N's forecast earnings growth (1.4% per year) is below the savings rate (7.7%).

Earnings vs Market: 1093 N's earnings (1.4% per year) are forecast to grow slower than the MX market (8.4% per year).

High Growth Earnings: 1093 N's earnings are forecast to grow, but not significantly.

Revenue vs Market: 1093 N's revenue (3.7% per year) is forecast to grow slower than the MX market (6.5% per year).

High Growth Revenue: 1093 N's revenue (3.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 1093 N's Return on Equity is forecast to be low in 3 years time (13.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y